Pharmamarketeer

FDA Approves Tolsura for the Treatment of Certain Systemic Fungal Infections

Tolsura is a new formulation of itraconazole, an azole antifungal, that utilizes the Company’s proprietary SUBA (SUper-BioAvailable) technology to improve the bioavailability of poorly soluble drugs.

Medhc-fases-banner
Advertentie(s)